APO RESEARCH · REPORT
Polio Vaccine
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
Product & engineering
Understand the product.
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
Selected research
Industry Research
Polio Vaccine Industry Research Report 2026
Market perspective
Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2016.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 91% market shares.
Read the full market overview
Report Scope
This report quantifies the global Polio Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Polio Vaccine Market by Company
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Polio Vaccine Segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Polio Vaccine Segment by Application
Public
Private
Polio Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polio Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polio Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polio Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Polio Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Polio Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Polio Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Inactivated Polio Vaccine (IPV)
- Oral Polio Vaccine (OPV)
Applications
- Public
- Private
Companies covered
- Sanofi
- GSK
- Bibcol
- Serum Institute
- Tiantan Biological
- IMBCA
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Polio Vaccine Market Size (2021-2032)
- 2.2.2 Global Polio Vaccine Sales (2021-2032)
- 2.2.3 Global Polio Vaccine Market Average Price (2021-2032)
- 2.3 Polio Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Inactivated Polio Vaccine (IPV)
- 2.3.3 Oral Polio Vaccine (OPV)
- 2.4 Polio Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Public
- 2.4.3 Private
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Polio Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Polio Vaccine Sales (M Doses) of Manufacturers (2021-2026)
- 3.3 Global Polio Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Polio Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Polio Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Polio Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Polio Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Polio Vaccine, Established Date
- 3.9 Global Polio Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sanofi
- 4.1.1 Sanofi Company Information
- 4.1.2 Sanofi Business Overview
- 4.1.3 Sanofi Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sanofi Polio Vaccine Product Portfolio
- 4.1.5 Sanofi Recent Developments
- 4.2 GSK
- 4.2.1 GSK Company Information
- 4.2.2 GSK Business Overview
- 4.2.3 GSK Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GSK Polio Vaccine Product Portfolio
- 4.2.5 GSK Recent Developments
- 4.3 Bibcol
- 4.3.1 Bibcol Company Information
- 4.3.2 Bibcol Business Overview
- 4.3.3 Bibcol Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bibcol Polio Vaccine Product Portfolio
- 4.3.5 Bibcol Recent Developments
- 4.4 Serum Institute
- 4.4.1 Serum Institute Company Information
- 4.4.2 Serum Institute Business Overview
- 4.4.3 Serum Institute Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Serum Institute Polio Vaccine Product Portfolio
- 4.4.5 Serum Institute Recent Developments
- 4.5 Tiantan Biological
- 4.5.1 Tiantan Biological Company Information
- 4.5.2 Tiantan Biological Business Overview
- 4.5.3 Tiantan Biological Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tiantan Biological Polio Vaccine Product Portfolio
- 4.5.5 Tiantan Biological Recent Developments
- 4.6 IMBCA
- 4.6.1 IMBCA Company Information
- 4.6.2 IMBCA Business Overview
- 4.6.3 IMBCA Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 IMBCA Polio Vaccine Product Portfolio
- 4.6.5 IMBCA Recent Developments
- 4.7 Panacea Biotec Ltd
- 4.7.1 Panacea Biotec Ltd Company Information
- 4.7.2 Panacea Biotec Ltd Business Overview
- 4.7.3 Panacea Biotec Ltd Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Panacea Biotec Ltd Polio Vaccine Product Portfolio
- 4.7.5 Panacea Biotec Ltd Recent Developments
- 4.8 Bio-Med
- 4.8.1 Bio-Med Company Information
- 4.8.2 Bio-Med Business Overview
- 4.8.3 Bio-Med Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bio-Med Polio Vaccine Product Portfolio
- 4.8.5 Bio-Med Recent Developments
- 4.9 Halfkin Bio-Pharmaceuticals
- 4.9.1 Halfkin Bio-Pharmaceuticals Company Information
- 4.9.2 Halfkin Bio-Pharmaceuticals Business Overview
- 4.9.3 Halfkin Bio-Pharmaceuticals Polio Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Halfkin Bio-Pharmaceuticals Polio Vaccine Product Portfolio
- 4.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
5 Global Polio Vaccine Market Scenario by Region
- 5.1 Global Polio Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Polio Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Polio Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Polio Vaccine Sales by Region: 2027-2032
- 5.3 Global Polio Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Polio Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Polio Vaccine Revenue by Region: 2027-2032
- 5.4 North America Polio Vaccine Market Facts & Figures by Country
- 5.4.1 North America Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Polio Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Polio Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Polio Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Polio Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Polio Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Polio Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Polio Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Polio Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Polio Vaccine Market Facts & Figures by Country
- 5.7.1 South America Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Polio Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Polio Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Polio Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Polio Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Polio Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Polio Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Polio Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Polio Vaccine Sales by Type (2021-2032) & (M Doses)
- 6.1.2 Global Polio Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Polio Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Polio Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Polio Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Polio Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Polio Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Polio Vaccine Sales by Application (2021-2032) & (M Doses)
- 7.1.2 Global Polio Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Polio Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Polio Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Polio Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Polio Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Polio Vaccine Value Chain Analysis
- 8.1.1 Polio Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Polio Vaccine Production Mode & Process
- 8.2 Polio Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Polio Vaccine Distributors
- 8.2.3 Polio Vaccine Customers
9 Global Polio Vaccine Analyzing Market Dynamics
- 9.1 Polio Vaccine Industry Trends
- 9.2 Polio Vaccine Industry Drivers
- 9.3 Polio Vaccine Industry Opportunities and Challenges
- 9.4 Polio Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst